These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37366033)

  • 41. Biostatistics: essential concepts for the clinician.
    Torres D; Normando D
    Dental Press J Orthod; 2021; 26(1):e21spe1. PubMed ID: 33729294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review of cluster randomised trials in residential facilities for older people suggests how to improve quality.
    Diaz-Ordaz K; Froud R; Sheehan B; Eldridge S
    BMC Med Res Methodol; 2013 Oct; 13():127. PubMed ID: 24148859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reporting of Basic Statistical Methods in Biomedical Journals: Improved SAMPL Guidelines.
    Indrayan A
    Indian Pediatr; 2020 Jan; 57(1):43-48. PubMed ID: 31937697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
    Piaggio G; Elbourne DR; Pocock SJ; Evans SJ; Altman DG;
    JAMA; 2012 Dec; 308(24):2594-604. PubMed ID: 23268518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sample size determination for BCI studies: How many subjects and trials?
    Melinscak F; Montesano L
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():1524-1527. PubMed ID: 28268616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reporting and methodological quality of sample size calculations in cluster randomized trials could be improved: a review.
    Rutterford C; Taljaard M; Dixon S; Copas A; Eldridge S
    J Clin Epidemiol; 2015 Jun; 68(6):716-23. PubMed ID: 25523375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A sample size planning approach that considers both statistical significance and clinical significance.
    Jia B; Lynn HS
    Trials; 2015 May; 16():213. PubMed ID: 25962998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fundamentals in Biostatistics for Research in Pediatric Dentistry: Part I - Basic Concepts.
    Garrocho-Rangel JA; Ruiz-Rodríguez MS; Pozos-Guillén AJ
    J Clin Pediatr Dent; 2017; 41(2):87-94. PubMed ID: 28288291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sample size calculations in surgery: are they done correctly?
    Maggard MA; O'Connell JB; Liu JH; Etzioni DA; Ko CY
    Surgery; 2003 Aug; 134(2):275-9. PubMed ID: 12947329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combining censored and uncensored data in a U-statistic: design and sample size implications for cell therapy research.
    Moyé LA; Lai D; Jing K; Baraniuk MS; Kwak M; Penn MS; Wu CO
    Int J Biostat; 2011; 7(1):. PubMed ID: 21841940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validity of sample sizes in publications of randomised controlled trials on the treatment of age-related macular degeneration: cross-sectional evaluation.
    Tulka S; Geis B; Baulig C; Knippschild S; Krummenauer F
    BMJ Open; 2019 Oct; 9(10):e030312. PubMed ID: 31601589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sample size calculations for evaluating a diagnostic test when the gold standard is missing at random.
    Kosinski AS; Chen Y; Lyles RH
    Stat Med; 2010 Jul; 29(15):1572-9. PubMed ID: 20552570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reporting quality of randomized controlled trials in otolaryngology: review of adherence to the CONSORT statement.
    Huang YQ; Traore K; Ibrahim B; Sewitch MJ; Nguyen LHP
    J Otolaryngol Head Neck Surg; 2018 May; 47(1):34. PubMed ID: 29764496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies.
    Wang X; Ji X
    Chest; 2020 Jul; 158(1S):S12-S20. PubMed ID: 32658647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the Quality of Pediatric Randomized Controlled Trials Published in Both Nursing and Medical Journals: Adherence to the CONSORT Statement.
    Devos F; Ibrahim N; Foissac F; Bouazza N; Ancel PY; Chappuy H; Elie C; Tréluyer JM
    Worldviews Evid Based Nurs; 2018 Dec; 15(6):447-454. PubMed ID: 30320961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.
    Laber EB; Zhao YQ; Regh T; Davidian M; Tsiatis A; Stanford JB; Zeng D; Song R; Kosorok MR
    Stat Med; 2016 Apr; 35(8):1245-56. PubMed ID: 26506890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.